Payments to Acquire Property, Plant, and Equipment of SAB Biotherapeutics, Inc. from 31 Dec 2020 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
SAB Biotherapeutics, Inc. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2020 to 31 Dec 2025.
  • SAB Biotherapeutics, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2024 was $129,074, a 506% increase year-over-year.
  • SAB Biotherapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2025 was $933,156, a 177% increase from 2024.
  • SAB Biotherapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $337,262, a 71% increase from 2023.
  • SAB Biotherapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $197,154, a 91% decline from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

SAB Biotherapeutics, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $933,156 +$595,894 +177% 01 Jan 2025 31 Dec 2025 10-K 09 Mar 2026 2025 FY
2024 $337,262 +$140,108 +71% 01 Jan 2024 31 Dec 2024 10-K 09 Mar 2026 2025 FY
2023 $197,154 -$1,969,260 -91% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
2022 $2,166,414 -$8,777,243 -80% 01 Jan 2022 31 Dec 2022 10-K 29 Mar 2024 2023 FY
2021 $10,943,657 -$1,788,045 -14% 01 Jan 2021 31 Dec 2021 10-K/A 28 Apr 2023 2021 FY
2020 $12,731,702 01 Jan 2020 31 Dec 2020 10-K/A 28 Apr 2023 2021 FY

SAB Biotherapeutics, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $129,074 +$107,774 +506% 01 Jan 2024 31 Mar 2024 10-Q 09 May 2025 2025 Q1
Q1 2023 $21,300 -$1,336,024 -98% 01 Jan 2023 31 Mar 2023 10-Q 20 May 2024 2024 Q1
Q1 2022 $1,357,324 -$532,832 -28% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q1 2021 $1,890,156 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.